Tag: Acquisition
Business & Industry
Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal
Gilead Sciences has agreed to acquire Germany-based Tubulis in a deal valued at $3.15 billion upfront, with an additional $1.85 billion tied to milestones,...
Business & Industry
Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition
Neurocrine Biosciences is close to securing a more than $2.5bn acquisition of Soleno Therapeutics, the developer of a treatment for a rare genetic form...
Business & Industry
Biogen to Acquire Apellis for $5.6 Billion in Major Deal
Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, in a move that significantly expands its presence in immunology and rare...
Business & Industry
Transcend Acquisition Advances Otsuka Neuroplastogen Focus
Japanese pharmaceutical company Otsuka has moved to deepen its presence in the emerging neuroplastogen space through an agreement to acquire Transcend Therapeutics, bringing with...
Business & Industry
Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline
Novartis has entered into an agreement to acquire biotech firm Excellergy, a move that will bring a next-generation anti-immunoglobulin e (IgE) programme into its...
Press Releases
CVC Welcomes Apollo as Minority Investor in Syntegon: Partnership to Accelerate Next Growth Phase
CVC reaffirms confidence in Syntegon's strategic direction and continued growth potential
Apollo acquires 37% minority stake and adds valuable expertise – particularly to...
News
Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach
In order to broaden its portfolio in imaging and cardiovascular medicine, Bayer has agreed to purchase two experimental diagnostic imaging agents from Attralus. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read